At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized, Multicenter, Observer-Masked Study to Compare Safety/Efficacy of Nebivolol Suspension 0.5% or 1.0%, or Timolol Suspension 0.5% to Timolol Solution 0.5% in Participants With Primary Open Angle Glaucoma or Ocular Hypertension
In Brief
A Phase 2 clinical trial evaluating Nebivolol Ophthalmic Suspension 1 Percent, Nebivolol Ophthalmic Suspension 0.5 Percent, and 2 other interventions for Open-Angle Glaucoma and Ocular Hypertension. Completed, enrolled 226 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the safety (in the eye and throughout the body) and effectiveness of nebivolol (0.5 and 1 percent) and timolol (0.5 percent) eye drop suspensions. These eye drops will be compared to timolol 0.5 percent eye drop solution in participants with open angle glaucoma (the most common type of glaucoma) or high eye pressure (ocular hypertension).
Study Details
Timeline
Interventions
1 drop instilled into each eye twice daily
1 drop instilled into each eye twice daily
1 drop instilled into each eye twice daily
1 drop instilled into each eye twice daily